Clinical trials of adult T-cell leukaemia/lymphoma treatment.
about
HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cellsSelective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemiaAdult T-Cell Leukemia-Lymphoma during PregnancyThe effect of the JAK2 inhibitor TG101209 against T cell acute lymphoblastic leukemia (T-ALL) is mediated by inhibition of JAK-STAT signaling and activation of the crosstalk between apoptosis and autophagy signaling.Viral Oncology: Molecular Biology and Pathogenesis.Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?
P2860
Clinical trials of adult T-cell leukaemia/lymphoma treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical trials of adult T-cell leukaemia/lymphoma treatment.
@en
type
label
Clinical trials of adult T-cell leukaemia/lymphoma treatment.
@en
prefLabel
Clinical trials of adult T-cell leukaemia/lymphoma treatment.
@en
P2093
P2860
P356
P1476
Clinical trials of adult T-cell leukaemia/lymphoma treatment.
@en
P2093
Ali Bazarbachi
Ambroise Marçais
David Sibon
Felipe Suarez
P2860
P304
P356
10.1155/2012/932175
P577
2012-02-14T00:00:00Z